Menu
23 Sep 2017 | 9:21 PM
 

Indoco Remedies Ltd. Share Price Live (BSE)
0

BSE Code: 532612 | NSE Symbol: INDOCO
200.10
-6.85
(-3.31 %)
22 Sep 2017 | 03:43 PM
Change company
  • Open (Rs)
    209.00
  • Prev. close (Rs.)
    206.95
  • High (Rs.)
    214.00
  • Low (Rs.)
    200.10
  • 52W H (Rs.)
    351.50
  • 52W L (Rs.)
    179.00
  • Volume (Rs.)
    13874
  • MCap (Rs in Cr.)
    1,843.93
F&O Futures F&O Options
Expiry Date
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
9.00
Operating Margin (%)
17.16
Gross Profit Margin (%)
11.15
Net Profit Margin (%)
8.26
Total Debt/Equity
0.22
Dividend payout Ratio (Net Profit)
21.39
Earning Retention Ratio
78.61

News

Indoco Remedies posts Q1 net loss of Rs 21.73 cr
09 Aug 2017 - 15:26:00-The company reported standalone net loss during the quarter stood at Rs 21...
Indoco Remedies posts Q1 net loss of Rs 21.73 cr
09 Aug 2017 - 15:26:00-The company reported standalone net loss during the quarter stood at Rs 21...
USFDA issues warning letter to Indoco Remedies' Goa plant
13 Apr 2017 - 11:49:00-The US Food and Drug Administration (USFDA) has issued a warning letter to Indoco Remedies for viola...
Indoco Remedies tanks over 16% on USFDA warning for Goa unit
03 Apr 2017 - 11:55:00-Shares of Indoco Remedies plunged over 16 per cent on the Bombay Stock Exchange after the drug maker...

Announcements

22-Sep-2017
Indoco Remedies - Disclosure under SEBI Takeover Regulations
22-Sep-2017
Indoco Remedies - Updates
07-Sep-2017
Indoco Remedies - Reply to Clarification Sought
04-Sep-2017
Indoco Remedies - Clarification
01-Sep-2017
Indoco Remedies - Change in Company Secretary/Compliance Officer

Religare Research

Master Pick Update - 22nd September 2017
22 Sep 2017 | 06:00 PM
This week, we haven’t initiated fresh position, citing excessive volatility and possibility of furth...
Religare Weekly Equity
22 Sep 2017 | 06:00 PM
It was a difficult week for the traders as the domestic benchmark index, Nifty, traded volatile and ...
Daily Forex and IRF Report
22 Sep 2017 | 10:04 AM
The Indian rupee posted the largest single-session decline against the dollar since May 18, after th...
Agri Fundamental and Technical report
22 Sep 2017 | 10:02 AM
Agri Fundamental and Technical report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
29,13,658 98.26 36.36 -2.32
29,13,658 98.26 59.88 -2.32
29,13,658 98.26 61.75 -2.32
29,13,658 98.26 37.49 -2.32
17,36,533 58.56 55.32 -2.81

Shareholding Pattern

       
Promotors59.11%
Mutual Funds/UTI8.48%
FI/Banks0.01%
Insurance0.01%
FII12.77%
Government0.00%
Others3.38%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,072.00(-1.98)
 11816
 Merck Ltd.
1,070.35(-2.35)
 3302
 Hester Biosciences Ltd.
1,033.00(-4.85)
 3572
 Neuland Laboratories Ltd.
1,016.00(-1.86)
 3578

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Indoco Remedies Ltd.8.6015.05-57.85
NIFTY(S&P CNX)198.85334.40933.95
BSE SENSEX630.59631.702,754.76
BSE 500382.97518.501,467.89

Corporate Details

Key Personal
Aditi Panandikar
Managing Director
Anand Nadkarni
Non Executive Director
Sundeep V Bambolkar
Joint Managing Director
Key Address
Registered Office
Indoco House 166 CST Road Kalina Santacruz (East),Mumbai,Maharashtra

Tel:022-26541851 26541852 26541853 26541854 26541855, Fax:022-26520787 66936241

compliance.officer@indoco.com
http://www.indoco.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C-13 Pannalal Silk Mill Compound LBS Marg Bhandup (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Indoco Remedies Ltd. that will help you decide whether to buy, sell or hold Indoco Remedies Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Indoco Remedies Ltd.

QUICK LINKS
RELIGARE ONLINE
IMPORTANT LINKS
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Securities Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Religare is a registered trademark of RHC Holding Private Limited used under license by Religare Enterprises Limited and its subsidiaries.
  • Member :
  • NSE: SEBI Regn. No: INB 230653732, INF 230653732 & INE 230653732 TM Co: 06537
  • Clearing Member (F&O) No. M50235 BSE:SEBI Regn. No: INB 010653732 & INF 010653732 |
  • Clearing No: 3004 |
  • MSEI SEBI Regn. No: INB260653739, INF260653739 & INE260653732 TM Co: 1051 Clearing Member (F&O) No. 51 |
  • NSDL: DP ID: IN 301774 |
  • SEBI Regn. No: IN-DP-NSDL-150-2000 |
  • CDSL DP ID: 30200 SEBI Regn. No: IN-DP-CDSL-202-2003 |
  • Research Analyst SEBI Regi. No.: INH100001831 |
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • NCDEX Emarket Member ID - 10042 |
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)